Eric M Janezic

8PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene and molecular therapyMolecular targetsCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 05, 2026
Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform.

|Apr 17, 2026
Molecular basis of CXC chemokine receptor 3 ligand multispecificity.

|Feb 19, 2026
Evaluation of RBC Targeting As a Strategy to Extend Half-Life and Reduce Nonspecific Tissue Uptake of Biologics.

Nicholas Cho, Hanine Rafidi, Travis Morgenstern

|Dec 01, 2023
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.

Dawei Sun, Yonglian Sun, Eric Janezic

|Oct 02, 2023
A novel, label-free, pre-equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells.

Eric M Janezic, Alexander Doan, Elaine Mai

|Sep 21, 2022
Antibody targeting of E3 ubiquitin ligases for receptor degradation.

Hadir Marei, Wen-Ting K Tsai, Yee-Seir Kee

Pageof 2

Frequent Collaborators

3 joint publications

Laëtitia Comps-Agrar

2 joint publications

Tricia Zhou

2 joint publications

Matthieu Masureel

1 joint publications

Hadir Marei